StockData
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. (SNOA) income statement

SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3082% below fair value
$0.83−0.01 (-0.76%)

Close on Nov 18, 2026Market cap $3.96MP/E –Yield –

Sonoma Pharmaceuticals, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
38.9%
Operating margin
-6.4%
Net margin
-10.3%
Return on equity, FY2026
-84.6%

Financial strength

Current ratio
2.99
Debt to equity
–
Debt to assets
–
Cash to current liabilities
98.0%

Valuation

P/E ratio
–
Price to sales
0.18
Price to book
0.60
Dividend yield
–

See a number that looks wrong?